{"database": "lobbying", "table": "lobbying_activities", "rows": [[3014926, "5e48f4cd-493f-4f73-b620-868377f4dd46", "Q2", "BUCHANAN INGERSOLL & ROONEY PC", 55291, "GENERIC ANIMAL DRUG ALLIANCE", 2023, "second_quarter", "PHA", "Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2023-07-19T12:04:46-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3014926"], "units": {}, "query_ms": 0.2792209852486849, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}